Idexx Laboratories earnings were $866.2M for the trailing 12 months ending Sep 30, 2024, with 5.7% growth year over year. The latest IDXX earnings report on Sep 30, 2024 announced Q3 2024 earnings of $232.8M, up 14.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, IDXX reported annual earnings of $845.0M, with 24.4% growth.
IDXX past earnings growth
How has IDXX's earnings growth performed historically?
What were Idexx Laboratories's earnings last quarter?
On IDXX's earnings call on Invalid Date, Idexx Laboratories (NASDAQ: IDXX) reported Q3 2024 earnings per share (EPS) of $2.83, up 10.98% year over year. Total IDXX earnings for the quarter were $232.84 million. In the same quarter last year, Idexx Laboratories's earnings per share (EPS) was $2.55.
As of the last Idexx Laboratories earnings report, Idexx Laboratories is currently profitable. Idexx Laboratories's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $866.24 million, a 5.29% increase year over year.
What was IDXX's earnings growth in the past year?
As of Idexx Laboratories's earnings date in Invalid Date, Idexx Laboratories's earnings has grown 5.65% year over year. This is 11.39 percentage points higher than the US Diagnostics & Research industry earnings growth rate of -5.74%. IDXX earnings in the past year totalled $866.24 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.